In plain language
Follistatin is a naturally occurring protein that binds and inhibits myostatin and related factors that limit muscle growth. Blocking myostatin produces dramatic muscle gains in animals, which drives interest in follistatin. Human data is limited mostly to early gene-therapy research, and injectable follistatin peptide lacks human trials.
What it is explored for
Follistatin sits at the center of one of the most exciting ideas in muscle science: releasing the body's natural brake on growth. The animal results are striking, but it is honest to say human evidence is early and mostly limited to gene-therapy research, with injectable peptide forms untested. Here is where interest and ongoing research are focused.
- Muscle growth and lean mass
- Myostatin inhibition research
- Strength and athletic performance
- Muscle-wasting and dystrophy research
- Body-composition and recovery interest
These are areas of active interest and reported use, not proven outcomes. This peptide carries a preliminary evidence rating, see the evidence summary below for how strong the science actually is.
How it works
Follistatin binds and neutralizes myostatin and activins, members of the TGF-beta family that normally restrain muscle growth, releasing that brake in research models.
- Myostatin inhibition. Binds myostatin, a negative regulator of muscle mass, which in animals leads to substantial muscle growth.
- Activin binding. Also neutralizes activins, affecting broader TGF-beta family signaling involved in tissue regulation.
- Local versus systemic. Much promising work uses gene therapy to express follistatin locally in muscle rather than injected peptide.
The most striking effects are in animal and gene-therapy models. Human data is early, and injectable follistatin peptide lacks controlled trials.
Evidence summary
Evidence for follistatin is preliminary in humans despite striking animal results. Myostatin inhibition reliably builds muscle in animals, and early follistatin gene-therapy trials have explored muscular dystrophies, but injectable follistatin peptide marketed for muscle gain lacks controlled human trials. Benefit and safety of that form in people are not established.
Reported safety & side effects
Human safety data for injectable follistatin is lacking. Because it disrupts a broad signaling family involved beyond muscle, theoretical concerns include effects on other tissues and reproduction. Long-term effects in people are unknown.
Frequently asked
Is follistatin FDA-approved?
No. Follistatin is not approved by the FDA for any use. It is sold as a research chemical, and follistatin gene therapy remains investigational.
Why is follistatin associated with big muscle gains?
It inhibits myostatin, the body's natural brake on muscle growth. Removing that brake produces dramatic muscle increases in animals, which is the basis for the interest, though injectable peptide forms lack human evidence.
Is there human evidence for injectable follistatin?
Not in controlled trials. Human work has centered on gene therapy for muscle diseases. The injectable peptide marketed for muscle gain has no controlled human trials, so its effects and safety are not established.